UVA Health Cancer Center is joining more than 50 other top cancer organizations in calling to increase access to and use of low-dose computed tomography (CT) scans for Americans at high risk for lung cancer.
UVA researchers have developed an algorithm that will improve cancer care by quickly and easily identifying patients who will benefit from powerful cancer drugs called kinase inhibitors.
Researchers at the School of Medicine and the UVA Biocomplexity Institute have been selected to help establish a national pathogen genomics surveillance network.
The discovery of a "master controller" for the brain's immune response could let doctors supercharge the body’s ability to fight a spectrum of devastating neurological diseases.
Newly discovered biological changes in mothers who suffer postpartum depression may help explain the condition, yield long-sought treatments and let doctors identify those at risk even before their babies are born.